KMDVX | VMVIX | KMDVX / VMVIX | |
Total Expense Ratio | 1.20 | 0.19 | 632% |
Annual Report Gross Expense Ratio | 1.41 | 0.19 | 742% |
Fund Existence | 14 years | 19 years | - |
Gain YTD | 7.773 | 6.022 | 129% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 126M | 32.5B | 0% |
Annual Yield % from dividends | 0.99 | 2.05 | 48% |
Returns for 1 year | -2.05 | 0.89 | -230% |
Returns for 3 years | 31.08 | 37.68 | 82% |
Returns for 5 years | 65.46 | 62.54 | 105% |
Returns for 10 years | 97.67 | 99.22 | 98% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
AVSF | 47.32 | 0.08 | +0.18% |
Avantis Short-Term Fixed Income ETF | |||
VSDM | 76.66 | 0.07 | +0.08% |
Vanguard Short Duration Tax-Exm Bd ETF | |||
MARB | 20.26 | N/A | -0.02% |
First Trust Merger Arbitrage ETF | |||
ITA | 206.25 | -1.43 | -0.69% |
iShares US Aerospace & Defense ETF | |||
XPH | 48.01 | -0.50 | -1.03% |
SPDR® S&P Pharmaceuticals ETF |